AstraZeneca announces sale of its West Chester, Ohio (US) manufacturing site
National Resilience, Inc. to expand site and support future growth of its medicines manufacturing capabilities.AstraZeneca today announces the sale of its West Chester site in Ohio, US, to National Resilience, Inc. (Resilience), a technology-focused manufacturing company dedicated to broadening access to complex medicines. Andrew Wirths, Senior Vice President, Americas Supply Region, AstraZeneca, said: “As part of our long-term strategy to ensure our global supply network remains fit for the future, we are continuously optimising our manufacturing footprint to meet the evolving needs of